Early gastric cancer was found, do not hurry to surgery
Here to remind the general public who, if they do not hurry to early gastric cancer surgery, would like to know the reasons, please read on.
Mr. Jiang accompanied his father on this day to go for endoscopy, usually does not have much time to think about their own to the hospital examination, and decided to also make a look at endoscopy. The results of eye-popping: Father apart from a few inflammation, did not cause illness, but Mr. Jiang himself, but found that the stomach!
Early detection is the lesser evil, Mr. Jiang is well positioned to endure knife preparation. Can doctor told Mr. Jiang that he might need surgery, because he was an early gastric cancer, that is, cancer exists only in his gastric mucosa layer, can be considered in the endoscopic be stripped.
Early gastric cancer, or can not have surgery
Traditional treatment of early gastric cancer is radical resection of gastric cancer, that is, the abdominal tumor with partial or total excision of gastric tissue together. The minimally invasive treatment is to remove the tumor by endoscopy and violations of the gastric mucosa. The specific process it simply is this: In the gastroscope, through into the colored liquid, so that tumor, "colored" to distinguish it from normal tissue; re-enter the liquid so that violations of the mucosa to muster, and other organizations, separate from the to; finally muster the mucosa and tumor strip. Surgical trauma, the next day will be able to eat, and the effects of general surgery, postoperative even a small impact on life.
Of course. To conduct minimally invasive treatment, need to be very strict inspection preoperative staging of the tumor can only be limited to the mucosa. In 2009 the latest version of "NCCN Clinical Practice Guidelines gastric I," put forward the updated requirements, limited to mucosa of patients with early gastric cancer, according to local infiltration depth and lymph node involving the continued refinement stage, in order to screen for appropriate patients.
Endoscopic treatment of early gastric cancer in Japan, such tube has been widely applied, but the application is still limited in China. Because, as a means of early diagnosis of gastric cancer endoscopy in the country yet to be a good promotion, like Mr. Jiang as an early discoverer less. According to statistics: Japan early gastric cancer diagnosis rate was 60%, while we only have 10%.
Therefore, early detection with the need for doctors and patients. Some hospitals are even responsible for endoscopy by nurses, doctors, early gastric cancer who was found ways to reward and encourage the promotion of gastric cancer, early detection, early treatment; for the people, for their own health, they should be more proactive participation physical examination. Because 5-year survival rate of gastric cancer, a gastric cancer after surgery can reach 95%, two gastric cancer have 80%, while the once in three, it will drop to 50%.
Early, and sometimes also chemotherapy
Mr. Jiang surgery well, but pathological results showed that "signet-ring cell carcinoma", the doctor advised him to do chemotherapy. Prior to, and his doctors have said, the cut end of the bin. Whether for early gastric cancer chemotherapy, have been controversial in the medical profession, but in case of risk factors, or to consider. Risk factors include: the pathology revealed a high degree of malignancy, such as the signet-ring cell carcinoma, gastric adenocarcinoma; young patients (such as 30 years of age), because these people tend to be more active in tumors. But also more demanding treatment outcome. In addition, doctors in the surgery to see if there is a special location of ulcer or tumor metastasis-prone, etc. also need to chemotherapy. In the past, gastric signet-ring cell carcinoma of the matter which period, the prognosis is very bad, and later combined with chemotherapy, which makes some patients can also be long-term survival.
The controversy stems from chemotherapy, doctors generally have significant adverse reactions, and had to be hospitalized, but also affect the patient's quality of life. Therefore, to measure its pros and cons of the patient As everyone big As everyone small. Now, the doctor will recommend chemotherapy for patients who need to "eat medicine", that is, choose a small can of oral toxicity of chemotherapy drugs, which is under option to measure the pros and cons.
In gastric cancer chemotherapy in the past, with more than one drug is 5-Fu uracil, past, and other chemotherapy drugs as an intravenous medication. The doctors recommend the use of less toxic oral chemotherapy drug capecitabine (Xeloda), the perspective of its kind in the world the latest in medicine, it passed into the gastrointestinal, after oral administration did not immediately become a toxic 5 1 FU uracil, so small gastrointestinal adverse reactions, and only later absorbed into the tumor, using an enzyme inside the tumor tissue can be transformed into 5 a Fu uracil play a lethal objectives are clear. And this role of normal tissues is much smaller. Capecitabine in the gastrointestinal tract to stay a long time and the concentration of large, rather than intravenous drug use, as the body can reach every place, it is especially applicable to the gastrointestinal tract tumor. And oral chemotherapy drugs doctors were prescribing drugs only after the return home on time and according to the amount you can take. Does not affect the life and work. Makes early gastric cancer is generally faster postoperative recovery of life and work.
China in the early detection of gastric cancer is still a minority, more patients are found to progress in a period of time, chemotherapy is very important or even the entire treatment is a major part.
Now know that early detection of gastric cancer, do not hurry to cut the bar!
